Fig. 2: Unadjusted cumulative incidence curve of post-acute mortality. | Nature Communications

Fig. 2: Unadjusted cumulative incidence curve of post-acute mortality.

From: SARS-CoV-2 rebound and post-acute mortality and hospitalization among patients admitted with COVID-19: cohort study

Fig. 2

A All patients. B Nirmatrelvir/ritonavir recipients. C Molnupiravir recipients. Solid lines represent the cumulative incidence in patients with virologic rebound (red) and patients without virologic rebound (blue). Shaded regions indicate 95% confidence bands. Tables represent numbers at risk during the follow-up period in patients with and without virologic rebound. VR virologic rebound.

Back to article page